Low-Level Viremia in HIV-1 Infection: Consequences and Implications for Switching to a New Regimen
Author:
- 1 April 2009
- journal article
- review article
- Published by Taylor & Francis in HIV Research & Clinical Practice
- Vol. 10 (2) , 116-124
Abstract
Virologic failure, or the inability to maintain or achieve viral suppression below detectable limits ( var addthis_config = {"data_track_addressbar":true,"ui_click":true}; Add to shortlist Link Permalink http://dx.doi.org/10.1310/hct1002-116 Download Citation Recommend to: A friendKeywords
This publication has 39 references indexed in Scilit:
- Antiretroviral Treatment of Adult HIV InfectionJAMA, 2008
- Persistent low‐level viraemia and virological failure in HIV‐1‐infected patients treated with highly active antiretroviral therapyHIV Medicine, 2006
- Immunologic and virologic evolution during periods of intermittent and persistent low-level viremiaAIDS, 2004
- HIV-1–Infected Antiretroviral-Treated Patients With Prolonged Partial Viral SuppressionJAIDS Journal of Acquired Immune Deficiency Syndromes, 2003
- Prevalence and clinical correlates of HIV viremia (`blips') in patients with previous suppression below the limits of quantificationAIDS, 2002
- HIV-1 Drug Resistance Profiles in Children and Adults With Viral Load of <50 Copies/mL Receiving Combination TherapyJAMA, 2001
- Clinical progression of HIV-1 infection according to the viral response during the first year of antiretroviral treatmentAIDS, 2000
- Use of Changes in Plasma Levels of Human Immunodeficiency Virus Type 1 RNA to Assess the Clinical Benefit of Antiretroviral TherapyThe Journal of Infectious Diseases, 1998
- Plasma Viral Load and CD4+ Lymphocytes as Prognostic Markers of HIV-1 InfectionAnnals of Internal Medicine, 1997
- Monitoring Plasma HIV-1 RNA Levels in Addition to CD4+ Lymphocyte Count Improves Assessment of Antiretroviral Therapeutic ResponseAnnals of Internal Medicine, 1997